Lowe M C, Smallwood J I
Cancer Chemother Pharmacol. 1980;5(1):61-5. doi: 10.1007/BF00578564.
Chemotherapeutic usefulness of adriamycin (ADR) and daunomycin (DAU), members of a large class of antitumor anthracyclines, is limited by a unique cardiotoxicity. Using spontaneously beating isolated myocytes from adult rat hearts, we have observed a relatively unique effect of these agents upon maximal contraction times. ADR and DAU induce cessation of beating in an identical dose-dependent manner, while two related anthracyclines exhibit similar inhibitory effects but at different concentrations. Other cytotoxic and antitumor agents tested failed to significantly affect maximal contraction times. This system may be useful in the evaluation of anthracycline analogs for cardiotoxic potential relative to ADR and DAU, as well as in studying the mechanisms of that toxicity. It may also prove useful in selective examination of the direct effects of other agents upon myocardial cells.
阿霉素(ADR)和柔红霉素(DAU)是一大类抗肿瘤蒽环类药物中的成员,它们的化疗效用受到一种独特心脏毒性的限制。利用成年大鼠心脏中自发跳动的分离心肌细胞,我们观察到这些药物对最大收缩时间有相对独特的作用。阿霉素和柔红霉素以相同的剂量依赖性方式诱导心跳停止,而另外两种相关的蒽环类药物表现出类似的抑制作用,但浓度不同。测试的其他细胞毒性和抗肿瘤药物未能显著影响最大收缩时间。该系统可用于评估蒽环类类似物相对于阿霉素和柔红霉素的心脏毒性潜力,以及研究该毒性的机制。它也可能被证明在选择性检查其他药物对心肌细胞的直接作用方面有用。